Torres Esteban M, Stewart M, Bragginton E, Meroni A, Pellizzari A, Jeanrenaud A
Life Sci Alliance. 2025; 8(5).
PMID: 40049731
PMC: 11884936.
DOI: 10.26508/lsa.202403074.
Sottnik J, Shackleford M, Nesiba C, Richer A, Swartz J, Rowland C
bioRxiv. 2024; .
PMID: 39677775
PMC: 11642799.
DOI: 10.1101/2023.10.29.564555.
Kelliher J, Folkerts M, Shen K, Song W, Tengler K, Stiefel C
Nat Commun. 2024; 15(1):4634.
PMID: 38821984
PMC: 11143218.
DOI: 10.1038/s41467-024-49071-w.
Xie Q, Liao Q, Wang L, Zhang Y, Chen J, Bai H
Reprod Sci. 2023; 31(1):30-44.
PMID: 37486531
DOI: 10.1007/s43032-023-01294-w.
Fan T, Kang H, Wu D, Zhu X, Huang L, Wu J
Nat Commun. 2022; 13(1):7942.
PMID: 36572675
PMC: 9792525.
DOI: 10.1038/s41467-022-35715-2.
In silico study reveals unconventional interactions between MDC1 of DDR and Beclin-1 of autophagy.
Pandya K, Singh N
Mol Divers. 2022; 27(6):2789-2802.
PMID: 36482226
DOI: 10.1007/s11030-022-10579-2.
New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors.
Folk W, Kumari A, Iwasaki T, Cassimere E, Pyndiah S, Martin E
Int J Mol Sci. 2021; 22(24).
PMID: 34948122
PMC: 8704450.
DOI: 10.3390/ijms222413324.
Low-Dose Pesticides Alter Primary Human Bone Marrow Mesenchymal Stem/Stromal Cells through ALDH2 Inhibition.
Foucault A, Ravalet N, Besombes J, Picou F, Gallay N, Babin L
Cancers (Basel). 2021; 13(22).
PMID: 34830855
PMC: 8616329.
DOI: 10.3390/cancers13225699.
Breakage of CRISPR/Cas9-Induced Chromosome Bridges in Mitotic Cells.
Rodriguez-Munoz M, Serrat M, Soler D, Genesca A, Anglada T
Front Cell Dev Biol. 2021; 9:745195.
PMID: 34650988
PMC: 8505897.
DOI: 10.3389/fcell.2021.745195.
O-GlcNAcylation Affects the Pathway Choice of DNA Double-Strand Break Repair.
Averbek S, Jakob B, Durante M, Averbeck N
Int J Mol Sci. 2021; 22(11).
PMID: 34071949
PMC: 8198441.
DOI: 10.3390/ijms22115715.
Mediator of DNA Damage Checkpoint 1 (MDC1) Is a Novel Estrogen Receptor Coregulator in Invasive Lobular Carcinoma of the Breast.
Sottnik J, Bordeaux E, Mehrotra S, Ferrara S, Goodspeed A, Costello J
Mol Cancer Res. 2021; 19(8):1270-1282.
PMID: 33947745
PMC: 8349796.
DOI: 10.1158/1541-7786.MCR-21-0025.
Identification of 10 Hub Genes and an miRNA-mRNA Regulatory Network in Acute Kawasaki Disease.
Ma J, Gui H, Tang Y, Ding Y, Qian G, Yang M
Front Genet. 2021; 12:585058.
PMID: 33868359
PMC: 8044791.
DOI: 10.3389/fgene.2021.585058.
BCAS2, a protein enriched in advanced prostate cancer, interacts with NBS1 to enhance DNA double-strand break repair.
Wang L, Chen T, Kang C, Huang H, Chen S
Br J Cancer. 2020; 123(12):1796-1807.
PMID: 32963349
PMC: 7723048.
DOI: 10.1038/s41416-020-01086-y.
Roles for MDC1 in cancer development and treatment.
Ruff S, Logan S, Garabedian M, Huang T
DNA Repair (Amst). 2020; 95:102948.
PMID: 32866776
PMC: 7669677.
DOI: 10.1016/j.dnarep.2020.102948.
Karyopherin α-2 Mediates MDC1 Nuclear Import through a Functional Nuclear Localization Signal in the tBRCT Domain of MDC1.
Radhakrishnan K, Park S, Kim S, Hariharasudhan G, Jeong S, Chang I
Int J Mol Sci. 2020; 21(7).
PMID: 32290222
PMC: 7177644.
DOI: 10.3390/ijms21072650.
MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells.
Singh N, Bhakuni R, Chhabria D, Kirubakaran S
BMC Res Notes. 2020; 13(1):146.
PMID: 32160908
PMC: 7066845.
DOI: 10.1186/s13104-020-04996-5.
Nuclear PARPs and genome integrity.
Azarm K, Smith S
Genes Dev. 2020; 34(5-6):285-301.
PMID: 32029453
PMC: 7050482.
DOI: 10.1101/gad.334730.119.
Crosstalk between PTEN/PI3K/Akt Signalling and DNA Damage in the Oocyte: Implications for Primordial Follicle Activation, Oocyte Quality and Ageing.
Maidarti M, Anderson R, Telfer E
Cells. 2020; 9(1).
PMID: 31947601
PMC: 7016612.
DOI: 10.3390/cells9010200.
MDC1 PST-repeat region promotes histone H2AX-independent chromatin association and DNA damage tolerance.
Salguero I, Belotserkovskaya R, Coates J, Sczaniecka-Clift M, Demir M, Jhujh S
Nat Commun. 2019; 10(1):5191.
PMID: 31729360
PMC: 6858307.
DOI: 10.1038/s41467-019-12929-5.
Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer.
Trevino V
Mol Genet Genomic Med. 2019; 7(8):e810.
PMID: 31294536
PMC: 6687632.
DOI: 10.1002/mgg3.810.